{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:30:04Z","timestamp":1759411804906},"reference-count":17,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.vaccine.2004.07.052","type":"journal-article","created":{"date-parts":[[2004,12,10]],"date-time":"2004-12-10T14:36:13Z","timestamp":1102689373000},"page":"2676-2679","source":"Crossref","is-referenced-by-count":34,"title":["BCG vaccine-associated suppurative lymphadenitis"],"prefix":"10.1016","volume":"23","author":[{"given":"Stephen S.S.","family":"Teo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima","family":"Smeulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delane V.","family":"Shingadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.07.052_bib1","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.052_bib2","first-page":"47","article-title":"Second IUATLD study on complications induced by intradermal BCG-vaccination","volume":"63","author":"Lotte","year":"1988","journal-title":"Bull Int Union Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2004.07.052_bib3","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2004.07.052_bib4","unstructured":"Troop, P. Important Information for Medical and Healthcare Professionals about new BCG Vaccine Statens Serum Institut (SSI). http:\/\/www.doh.gov.uk\/bcg\/bcgletter.pdf (accessed 27 January 2004)."},{"key":"10.1016\/j.vaccine.2004.07.052_bib5","series-title":"Handbook of paediatric dermatology","author":"Harper","year":"1985"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.052_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"4947","key":"10.1016\/j.vaccine.2004.07.052_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bmj.2.4947.1048","article-title":"Suppurative lymphadenitis following BCG vaccination of the newborn: a preliminary report","volume":"II","author":"Guld","year":"1955","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2004.07.052_bib8","unstructured":"WHO Tuberculosis Research Office. Suppurative lymphadenitis following intradermal BCG vaccination of pre-school children. Bull World Health Organ 1955;12:143\u201367."},{"key":"10.1016\/j.vaccine.2004.07.052_bib9","unstructured":"Statens Serum Institut. Summary of Product Characteristics: BCG Vaccine, MRP-SPC. http:\/\/www.serum.dk\/sw2853.asp (accessed 31 March 2004)."},{"key":"10.1016\/j.vaccine.2004.07.052_bib10","unstructured":"Evans Vaccines. Summary of product characteristics. June 2002."},{"issue":"5","key":"10.1016\/j.vaccine.2004.07.052_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/adc.71.5.446","article-title":"Needle aspiration for suppurative post-BCG adenitis","volume":"71","author":"Banani","year":"1994","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.052_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00006454-199302000-00006","article-title":"Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guerin lymphadenitis and abscesses","volume":"12","author":"Noah","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.052_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00006454-199806000-00020","article-title":"Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guerin lymphadenitis","volume":"17","author":"Kuyucu","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.052_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00006454-200106000-00020","article-title":"Treatment of Calmette-Guerin bacillus adenitis: a metaanalysis","volume":"20","author":"Goraya","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.07.052_bib15","unstructured":"North East London TB Network. Tuberculosis Notifications, 1987\u20132003. Rates per 100,000 population. Connections: The Newsletter of the North East London Tuberculosis Network (issue 6); March 2004."},{"key":"10.1016\/j.vaccine.2004.07.052_bib16","unstructured":"Tuberculosis Section Communicable Disease Surveillance Centre London. Preliminary annual report on tuberculosis cases reported in 2002 in England, Wales and Northern Ireland; March 2004. http:\/\/www.hpa.org.uk\/infections\/topics_az\/tb\/pdf\/2002_Preliminary_Annual_Report.pdf (accessed 31 March 2004)."},{"key":"10.1016\/j.vaccine.2004.07.052_bib17","unstructured":"Department of Health. Tuberculosis: BCG immunisation. In: Immunisation against Infectious Disease. http:\/\/www.doh.gov.uk\/greenbook\/greenbookpdf\/chapter-32-layout.pdf (accessed 27 January 2004)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:58:58Z","timestamp":1548975538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04008667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":17,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0264410X04008667"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.07.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}